In the brain of patients with mild cognitive impairment (MCI) and those with AD, the level of markers of oxidative damage to DNA, proteins, and lipids is increased, while the expression and activities of glutathione and antioxidant enzymes are reduced (reviewed in 102)
and encapsulation into nanoparticles, liposomes, phytosomes, polymeric micelles, and cyclodextrins (reviewed in 17)
References: Leikin, JB et al (2002): A review of nerve agent exposure for the critical care physician
CJC-1295, Ipamorelin, Tesamorelin, and Sermorelin are typically administered subcutaneously, usually in the abdomen
HUBERMAN: And we plan to have at least one of them on the Huberman Lab podcast as a guest in the not too distant future